Мы используем файлы cookie.
Продолжая использовать сайт, вы даете свое согласие на работу с этими файлами.
Antiinfective agent stubs
Amdoxovir
Другие языки:

Amdoxovir

Подписчиков: 0, рейтинг: 0
Amdoxovir
Amdoxovir.svg
Clinical data
ATC code
  • none
Identifiers
  • [(2R,4R)-4-(2,6-diaminopurin-9-yl)-1,3-dioxolan-2-yl]methanol
CAS Number
PubChem CID
ChemSpider
UNII
KEGG
ChEMBL
NIAID ChemDB
Chemical and physical data
Formula C9H12N6O3
Molar mass 252.234 g·mol−1
3D model (JSmol)
  • n2c1c(nc(nc1n(c2)[C@@H]3O[C@@H](OC3)CO)N)N
  • InChI=1S/C9H12N6O3/c10-7-6-8(14-9(11)13-7)15(3-12-6)4-2-17-5(1-16)18-4/h3-5,16H,1-2H2,(H4,10,11,13,14)/t4-,5-/m1/s1 checkY
  • Key:RLAHNGKRJJEIJL-RFZPGFLSSA-N checkY
  (verify)

Amdoxovir is a pharmaceutical drug that has undergone research for the treatment of HIV/AIDS. It acts as a nucleoside reverse transcriptase inhibitor (NRTI). The drug was discovered by Raymond F. Schinazi (Emory University) and C.K. Chu (University of Georgia) and developed by RFS Pharma.

Amdoxovir was in advanced Phase II clinical trials around 2010. In 2013, a Phase II trial was terminated and another was withdrawn before it started. No further studies appear to have been done.


Новое сообщение